CompuGroup Medical SE & Co. KGaA confirmed its ambition to achieve an organic year-on-year revenue growth of 5% and more per year from 2021 through 2025.
In addition, the company has now also adopted targets for the medium-term increase in adjusted EBITDA margin for the first time. Accordingly, It aims to increase the adjusted EBITDA margin to approximately 25% in 2023 and to about 27% in 2025.
The company confirmed the full year 2021 guidance. It expects revenues in 2021 to be in a range of 1 billion euros and 1.04 billion euros as well as adjusted EBITDA between 210 million euros and 230 million euros.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.